Predictive factors in Capecitabine plus CDDP therapy in patients with HER2 negative advanced gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 23 Feb 2018 Status changed from active, no longer recruiting to completed.
- 22 Aug 2012 Planned end date changed from 1 Jul 2013 to 31 Aug 2014 as reported by University Hospital Medical Information Network - Japan.
- 04 Apr 2012 Planned end date (Jul 2013) added as reported by University Hospital Medical Information Network - Japan.